Molecular imaging is rapidly developing as a powerful tool in research and medical diagnostic. By integrating complementary signal reporters into a single nanoparticulate contrast agent, multimodal molecular imaging can be performed as scalable images with high sensitivity, resolution and specificity. In this review, multifunctional nanoparticles (MFNPs) are classified into four types: conjugation, encapsulation, core/shell, and co-doping. Further, new constructs of MFNPs were reported recently which have used nanoparticulate contrast agent such as quantum dots (QDs), iron oxide nanoparticles (IONPs), Upconversion nanoparticles (UCNPs), carbon based nanoparticles, gold nanoparticles (Au-NPs), Metal-Organic Frameworks (MOFs), dendrimers and porphyrins based nanoparticles. Different surface modification strategies were also developed as well as ligands are attached to those NPs to render the biocompatibility and enable specific targeting. These new development in MFNPs are expected to introduce a paradigm shift in multi-modal molecular imaging and thereby opening up an era of personalized medicine and new diagnostic medical imaging tools. Parasuraman Padmanabhan is a Deputy Director, Translational neuroscience in Lee Kong Chian (LKC) School of Medicine, NTU. His expertise in multimodal molecular imaging approaches in preclinical area of research. He has a very strong and solid scientific background in cell and molecular biology, mizrobial genetics, probe development and molecular imaging. He has had the opportunity in his studies and in his professional scientific career, which had taken him across many destinations to experience a wide range of scientific environmental settings. He has more than twenty five years of research and teaching experience gained from several leading universities, such as Cornell and Stanford University, USA and also from SBIC, a A * STAR R&D Research Institute, which is one of the premier institute in Asean region.
INTRODUCTION
Over the past decade, molecular imaging has emerged as a powerful tool to investigate the biological activities in the cellular and subcellular level. [1] [2] [3] Usually, molecular imaging utilizes a specially designed biomarker, which can target to specific cells or molecules, and generate detectable signals. Compared to the clinically available medical imaging techniques, most of them mainly focuses on macroscopic physical, physiological or functional alterations; the multimodal molecular imaging is capable of revealing the underlying molecular and cellular pathway, which is responsible for certain biological phenomena. 2 Novel molecular imaging applications are expected to enhance our understanding of Haibin Su is an Associate Professor at NTU. He graduated from Stony Brook University, while performing his thesis projects in Center for Data Intensive Computing at Brookhaven National Laboratory. Then he went to California Institute of Technology for taking a 3-year PostDoc position in Professor William A. Goddard's research center prior to joining NTU. His research interest includes development and application of theoretical and computational physical science: i.e., quantum-mechanical and classical simulations and modeling of the structural, kinetic, and dynamic properties of complex functional systems, in particular emergent collective properties at multiple spatial and temporal scales.
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Balázs Gulyás is a Professor in LKC School of Medicine, NTU. Prior to this appointment, Professor Gulyás spent most of his scientific career at the world-renowned Karolinska Institutet, Stockholm, Sweden. During the past years his research focused on molecular neuroimaging with PET, with special regard to neurological and psychiatric diseases and their "humanised" small animal disease models. Professor Gulyás has published numerous books, written over 35 book chapters and contributed to over 180 research papers in peer reviewed scientific journals. He is a member of Academia Europaea (The Academy of Europe), the Hungarian Academy of Sciences and the Royal Belgian Academy of Medical Science. 4 Currently, multiple modalities are being applied to perform molecular imaging. However, no single modality can provide all the required information due to their inherent limitation. Table I summarizes the advantages and disadvantages of commonly used molecular imaging techniques. The idea of combing two or more complementary modalities together to obtain synergic effect is widely accepted in the research community. 1 2 6 7 For example, optical imaging is highly sensitive, and can achieve a temporal resolution in the second scale, but its spatial resolution and in vivo penetration depth are limited. On the other hand magnetic resonance imaging (MRI) is capable to achieve high spatial resolution Table I . Advantages and disadvantages for commonly used molecular imaging techniques.
Imaging technique
Contrast mechanism Advantages Disadvantages Contrast agent
Optical imaging [16] [17] [18] Photon emission • Non-metal Isotope: 18 F, 11 C • Metal Isotope: 64 Cu, 86 Y, 68 Ga. 99m Tc, 123 I, 111 In, 177 Lu Photoacoustic tomography 27 28 Photon absorption • Deeper penetration compare to optical imaging • Scalable imaging • Non-ionizing
• Deeper penetration and higher resolution cannot be obtained simultaneously.
• Organic dye • Gold nanoparticles • Carbon Nanotube
Optical coherence tomography [29] [30] [31] Light reflection and practically infinite penetration depth. 2 By combining these two modalities, High resolution and excellent sensitivity can be obtained simultaneously. 6 7 While great effort has been made in designing hybrid molecular imaging instruments (e.g., PET/CT and PET/MRI system. 6 8 ), the requirement of a single probe with multiple signaling capacities has arisen. Compared to individual single modality contrast agents, multimodality probe provides better image registration, consistent pharmacokinetics and reduced administration load for the patient. 6 Among the few candidates for multimodality imaging probe, multifunctional nanoparticles (MFNPs) has been attracting most of the researchers' interests due to a number of advantages: stronger and more stable contrast enhancement (e.g., quantum dots vs. fluorescent 9 ) large surface area for modification and ligand attachment, 10 prolonged circulation time 11 (However, this may also lead to increased cytotoxicity 12 ), and better tumor targeting through enhanced permeability and retention (EPR) effect. 13 Nanoparticles are normally 100-10000 times smaller than cells and hence can be easily internalized by cells.
14 More excitingly, wide loading ability of nanoparticles has made it possible to simultaneously load diagnostic and therapeutic moiety into one package, which initiate the idea of theranostics. 15 In contrast to the conventional "diagnostic followed by therapy" approach, theranostics helps to eliminate the discrepancy in biodistribution and selectivity between separated imaging and therapeutic agent (Fig. 1) . The ultimate goal of theranostics is to shift the current generalized medicine, which applies similar therapy to all patients with the same disease, into an era of personalized medicine, i.e., tailormade therapy for an individual patient. So far, a series of attempts has been reported to integrate MFNPs with agents for Gene therapy, chemotherapy, hyperthermia therapy, photodynamic therapy, and radionuclide therapy. 15 In this review, we have summarized some of the recent progress on developing MFNPs. The main focus is on integrated MRI/Optical probes while some probes that can be applied in other imaging modalities are also included. Those nanoparticles are made either by de novo synthesis or by integration of commercially available contrast agent. Most of the nanoprobes described in this review were reported in the past 5 years (from 2009). For nanoprobes that have been reported before 2009, several reviews are already available. 6 7 34 
NANOPARTICLE DESIGN
While some of the MFNPs used for molecular imaging are produced as by product or 'happy coincidence' from researches targeted for non-imaging application, most of the reported MFNPs are carefully designed to meet a certain requirement. The following four factors need to be determined during the design of MFNPs. Modalities to be Integrated The modalities that the MFNP can be used should be complementary to each other. The aforementioned MRI/Optical integration is one of the most widely studied combinations in MFNPs. Other combinations including MRI/PET, Optical/PET and Optical/CT have also been extensively explored. More-over, MFNPs with triple or more signal-reporting capabilities have been synthesized with carefully designed protocols. [35] [36] [37] [38] A major challenge in the design of MFNPs is to balance the sensitivities between different modalities, which may vary up to 3 orders of magnitude. 39 Luckily, the large surface area of NPs can serve to overcome this problem by controlling the moiety ratio between two contrast agents. It is also important that the integration of multiple agents should not produce detrimental effects to the performance factor of each agent. Different imaging modalities rely on different properties to generate the contrast and hence their performances are evaluated accordingly. For example, MRI contrast agents enhance the contrast by accelerating the relaxation processes of neighboring water protons. There are two types of relaxation process: longitudinal relaxation (T 1 and transverse relaxation (T 2 . One particular contrast agent mainly accelerates on the relaxation processes and hence MRI agents can be classified into T 1 and T 2 agents. The ability of one agent to affect the relaxation process is defined as r 1 or r 2 relaxivity, corresponding to the two types of relaxations. 40 For optical imaging, the quantum yield and excitation/emission wavelength are very important for the imaging resolution, signal-to-noise ratio and penetration depth. 9 An MRI/Optical bi-modal probe synthesized by integrating a MRI agent and an optical agent should exhibit similar relaxivity and optical properties compared to the stand-alone contrast agent.
Configuration of MFNP
We classify the configuration of MFNPs into the following four categories: conjugation, encapsulation, core/shell, co-doping (Fig. 2) reaction that could be more time consuming and complicated. Co-doped MFNPs can be prepared by facile onestep routes and are generally smaller in size. For different MFNPs, certain configuration may provide the best integration. Appropriate configuration can also help to reduce the interference between contrast agents. However, the actual configuration of MFNPs may be a mixture of two of more types. An encapsulation complex can be further conjugated to targeting agent, and a core/shell nanoparticle may also be doped to yield more functions.
Size
The size of MFNP plays a major role in determines its biodistribution, clearance, contrast enhancement and the cells that can be targeted. Small nanoparticles (<5.5 nm) will be quickly cleared out through renal system, while larger nanoparticles are mainly captured by the reticuloendothelial system (RES), resulting in much longer circulation time and liver accumulation. 41 However, if the nanoparticles are too large, the chance of RES take-up will increase, leading to a shorter half-life. Longer halflife is generally desired since it gives MFNPs enough time to extravasate out of the vasculature. The size also affects the targeting efficacy of MFNPs. For instance, large NPs (>100 nm) are quickly cleared from plasma to the spleen, liver and bone marrow. Hence those NPs should be designed to target those organs. On the other hand, smaller NPs (<30 nm) should be designed to target tumor, due to their long circulation time and EPR effect. 39 42 For quantum-dots based MFNP, the wavelength of fluorescent emission is also affected by its size, which give the QD based MFNPs an advantage of tunable emission through size control. 9 For Gd 3+ doped MFNPs, the size of NPs determines the number of surface Gd 3+ , and consequently affects the NPs' relaxivity. 43 
Surface Treatment
Surface treatment is very important to control the MFNPs' circulation time, biocompatibility and targeting efficiency. Many as synthesized NPs are coated with hydrophobic molecules. For bio-imaging application, those NPs need to be dispersed in an aqueous solution by hydrophilic capping agent. The capping can also provide surface functional groups to conjugate with other functional moieties. 44 One widely used capping material is polyethylene glycol (PEG) and its derivatives. Surface PEG layer can shield the nanoparticles from reticuloendothelial system (RES) by minimizing plasma protein binding, and this kind of capped nanoparticle are often referred as stealth particle. PEGlytion is widely used to increase the circulation time of NPs. [45] [46] [47] PEGylation has also been used to enhance tumor targeting of NPs due to the high affinity between cancer cells and PEG cappings. 48 49 Other capping agents that do the same thing have also been exploited, including poly acrylic acid (PAA), 12 50 polyethyleneimine (PEI), 51 and polyhedral oligomeric silsesquioxanes (POSS). 52 To further enhance the specific targeting and internalization of nanoprobe, biorecognition ligands, such as antibodies, peptides and aptamers, are often conjugated to the MFNPs' surface. 53 Due to different surface treatment, MFNPs with the same core size may have much different hydrodynamic diameter, which leads to different circulation and clearance behavior.
QUANTUM DOTS
Quantum dots (QDs) are nano-sized semiconductor crystals. Compare to conventional organic fluorescent dyes, QDs have some significant advantages including: high photostability, wide absorption, tunable emission, high quantum yield, large Stokes shift and long fluorescence lifetime. 9 Hence a significant effort has been put on developing QD based MFNPs. Most reported QDs are synthesized with hydrophobic capping molecules; additional encapsulation by amphiphilic surfactant or ligand exchange is required before applying the QD as molecular probes. Normally, encapsulation will produce much larger QDs compared to QDs undergoes ligand exchange. 54 The second contrast agent can be doped during QD preparation, incorporated during the encapsulation process or conjugated to the surface of those hydrophilic QDs.
In the work by Liu et al., CdTe/ZnS core/shell QDs were synthesized and capsuled using mPEG-phospholipid (mPEG-NH 2 -2000) Fig. 3(a) ). The high luminescence was retained with a red shift of 20-40 nm (Fig. 3(b) ). The different composition of the micelles resulted in different particle sizes: 10.8 ± 2.5 nm for PEG-QDs and 22.1 ± 5.7 nm for F127-QDs. However, this estimation was conducted under transmission electron microscopy (TEM), which means the estimated sized is most likely the core diameter and the micelle shell is ignored. In order to chelate with Gd 3+ , the QD micelles were mixed with DOTA-NHS-ester, strong amide bond formed between the surface amine and the DOTA-NHS. Then GdCl 3 was added into the solution and the Gd 3+ was chelated by DOTA. A difference in the relaxivities of the two nanoparticles (4.380 mM −1 s −1 for PEG-QD-Gd and 8.168 mM −1 s −1 for F127-QD-Gd, tested in 4.7T magnetic field) indicates that the amounts of conjugated Gd-DOTA chelators are different. The hydrodynamic diameters were found to be ∼60 nm for PEG-QD-Gd and 90 nm for F127-QD-Gd. In vitro cell imaging was performed on RAW264.7 macrophage cell lines and both QDs showed significant cellular uptake and intracellular luminescence. However, no MRI was conducted. Cytotoxicity of the two QDs was determined by cell viability (MTS) assay (Fig. 3(c) ). F127-QD-Gd was found less toxic than PEG-QD-Gd. The author argued that both QDs could be considered as biocompatible since the concentration used in the MTT essay is much than previous reported studies.
Also using Gd-DOTA chelator, Jin et al. functionalized the hydrophobic CdSeTe/CdS QDs by coating the QD with glutathione (GSH), and then conjugated with Gd-DOTA complex. 56 The GSH coated QD retained 60% of its luminescence. The conjugation of Gd-DOTA increased the hydrodynamic diameter from 7.0 ± 0.4 nm to 10 ± 0.2 nm. The T 1 relaxivity was measured to be 365 mM −1 s −1 . The large number of Gd 3+ conjugated in one QD might cause such a high relaxivity. NIR-fluorescence imaging and MRI was performed on a mouse to demonstrate the in vivo imaging utility of the Gd-DOTA-QDs (Fig. 4) .
Doping has also been used to synthesis multimodality QDs. Saha of 10%-67.5%. The T 2 relaxivity of the NIR (738 nm) emitting QD was measured to be 3.6 mM −1 s −1 (4.7T). Unfortunately, direct doping to the QDs' core may cause fluorescent bleaching due to the introduced impurities. Since QDs are often coated with a protective shell to prevent environmental degradation and toxic ion leakage, doping to the shell becomes an alternative to render multimodalities. Wang et al. capped a CdSe QDs with manganese doped ZnS shell (Fig. 5) . 50 CdSe QDs were first synthesized by mixing cadmium acetate and Se into hot TOPO (Trioctylphosphine oxide) solution. Then 1.5 to 6 monolayers of Zn-Mn-S shell was grown onto the surface of CdSe QDs. The Mn/Zn ratio is tuned by adjusting the amount of diethylzinc and dimethylmanganese. The manganese concentration ranges from 0.6% to 6.2% and the T 1 relaxivity ranges from 10 mM −1 s −1 to 13.1 mM
The core/shell QDs were made water dispersible by capping with octylamine-modified poly acrylic acid. The core size of the capped QDs were measured to be 4.7 nm using TEM. The quantum yield was reduced from 60% to 21% before and after organic coating. Fluorescence cell imaging and MRI of cell lysates were conducted to demonstrate the functionality imaging potential of the doped magnetic QDs. Due to the concern about potential leakage of highly toxic cadmium ions, researchers have attempted to synthesis non-cadmium based QD (e.g., ZnO, [58] [59] [60] ZnS, 61 62 InP, 63 64 CuInS 2 65 ), and many of those QDs are also used to produce multimodality probes. Lin et al. reported a CuInS 2 /Zn 1−x Mn x S Core/Shell QDs. 65 It also has a manganese-doped shell, similar to Wang's QD, but the core is composed of CuInS 2 instead of CdSe. The quantum yield reaches 18% in water and the T 1 relaxivity was measured to be 7. 58 Interestingly, the size of the ZnO QDs became smaller with increasing molar ratio of Gd/Zn (diameter of undoped ZnO QDs = 6 nm, diameter of Gd-doped ZnO QDs = 4 nm when Gd/Zn = 0 08). No significant lattice distortion was observed at low Gd ratio (Gd/Zn < 0.08). The doped Gd 3+ also enhanced the fluorescence of ZnO QDs. The QY increased from 13.5% (undoped ZnO QD) to 34% (when Gd/Zn = 0 08). Further increasing the Gd content significantly reduced the emission intensity. The author attributed this fluorescence enhancement to the increased oxygen vacancy that is origin of ZnO QDs' visible emission. According to a previous report, smaller ZnO QDs generally have more oxygen vacancy. 59 At very high Gd 3+ content, the fluorescence enhancing effect due to size reduction is overwhelmed by the detrimental effect of ZnO consumption. The T 1 relaxivity of the Gd-doped QDs was 16 mM −1 s −1 (Gd/Zn = 0 08, measured at 1.5T). Successive confocal laser-scan imaging and MR imaging was conducted on HeLa cells incubated with Gd-doped ZnO QDs. But the short excitation wavelength ( = 340 nm) may hinder its in vivo application.
Fluorescent silicon QD is another attractive candidate for multimodality bioimaging due of its inertness and low cytotoxicity. Either doping, 67 and 4d metals. 72 The calculation result shows that magnetic moments of most transition metals are completely quenched after doping into Si-QDs, while certain 3d metals (V, Cr, Mn, Nb, Mo, and Tc) still retain some of their magnetic moment after doping. Among those metals, Mn is considered the optimum choice since Mn-Si bonds have similar length of Si-Si bonds.
Consistent with Ma et al.'s study, Tu et al. reported water-dispersible Mn doped Si QDs for MR and twophoton imaging of macrophage. 68 The QDs were synthesized by refluxing Mn-doped sodium silicide in DMF, with NH 4 Br and allylamine added. The sodium silicide was prepared by ball-grinding of NaH, Si and Mn mixture, followed by heat treatment at 420 C for 48 hours and at 500 C for additional 24 hours. The surface -NH 2 groups of the as prepared QDs make it possible to coat the QD with dextran sulfate, which targets the macrophage SR-A receptor. The coating also caused particles aggregation: around 5-10 Mn doped Si nanoparticles bound together, formed nanoclusters with average size of 15-30 nm (Figs. 6(a-c)). For single-photon excitation, emission peak was observed at 441 nm under 360 nm excitation. For two-photon excitation, emission peak appeared at 478 nm under 790 nm excitation. The Si QDs also possess excellent MR properties with T 1 relaxivity of 25.50 ± 1.44 mM
The dual-modality of the Si QDs and specific targeting was further demonstrated by in vitro imaging of P388D1 murine macrophage cells.
As most of the as-synthesized Si ODs are hydrophobic, they can be encapsulated inside lipid micelles, and magnetic moiety can be incorporated inside the micelle core or to the lipid monolayer. Erogbogbo et al. reported co-capsulation of hydrophobic Si QDs and superparamagnetic iron oxide NPs (SPIONs) with phospholipid polyethylene glycol (DSPE-PEG) micelles. 71 The micelle was successfully applied for optical imaging on tumorbearing mice. The magnetic property was determined by vibrating sample magnetometer, but no MR imaging was performed. The same group also reported Gd 3+ -chelated Si QD micelles. The Si QDs were caped with amine-terminated DSPE-PEG, and then conjugated with DOTA-GD 3+ complex. The T 1 relaxivity of the synthesized NPs (2.43 mM −1 s −1 is comparable with commercial available Gd based MRI contrast agent. 70 
IRON OXIDE NANOPARTICLES
Iron oxide nanoparticles (IONPs) are being widely employed as T 2 MRI contrast agent. Compare to gadolinium based contrast agent, IONPs are less toxic (LD 50 for iron: 450 mg/kg, LD 50 for Gd 3+ : 88 mg/kg. 6 . For biomedical application, IONPs need to be water dispersible and biocompatible; this is normally achieved by coating with hydrophilic organic molecule such as PEG or dextran. 34 Further surface modification enables IONPs to be conjugated with other contrast agent and become multifunctional. Core/Shell configuration is also popular in which IONPs are functionalized with organic or inorganic shell. 73 A magneto-fluorescent nanoprobe with a typical conjugation configuration was reported by Ke et al. 12 Fe 3 O 4 nanoparticles were decorated by poly(acrylic acid) and became water-dispensable. This decoration also introduced free carboxyl groups to the surface. To make the NP fluorescent, Rhodamine 123 (Rh123) dye was covalently attached to the poly(acrylic acid) iron oxide (PAAIO). In addition, folic acid-linked PEG was conjugated to the PAAIO-Rh123. The folic acid helps specific targeting of cancer since folate receptor density was found increased in aggressive or undifferentiated tumors. Similar work was reported by Yen et al.: NIR IR-820 dyes were linked to amphiphilic poly-(isobutylene-alt-maleic anhydride), and then the dye-polymer complexes were conjugated to Fe 3 O 4 NPs to produce NIR/MRI bi-modal probes. 74 Ma et al. reported a multilayered core/shell nanoparticle with a magnetic Fe 3 O 4 nanoparticle (MNPs) core and three layers of silica shell. 75 The inner layer protects the IONP. The middle silica layer encapsulates visible emission (600 nm) CdSe/ZnS QDs. And the outer layer encapsulates NIR emission (780 nm) CdSeTe/CdS QDs. Anti-HER2 antibodies were also attached to the nanoparticles as specific binding ligands to human breast cancer cells (KPL-4). The nanoparticles were synthesized through a step-wised route, at each step, hydrolysis of TEOS produce a silica shell by reverse microemulsion. Functional groups were introduced to the final surface by reaction with 3-aminopropyltrimethoxysilane (APS). The inert silica shell prevents potential heavy metal leakage. The mean size of the synthesized probe is 150 nm, which is considerably large and may cause fast clearance. However, for in vivo imaging, the middle VIS-QDs containing silica layer may not be required as it provides similar information with NIR QDs but less penetration depth. In vivo NIR and MR imaging were performed on nude mice with transplanted KPL-4 cells (human breast cancer cell). Manganese (Mn) can be doped to IONPs to enhance its T 2 relaxivity, Kim et al. demonstrated a robust method to synthesis MR/NIR bimodal probe containing MnFe 2 O 4 NPs and NIR QDs in a polyelectrolyte nano complex. 76 Hydrophobic MnFe 2 O 4 NPs were first prepared by thermal decomposition. Then the MnFe 2 O 4 NPs were made water dispersible by capping with negatively charged poly( -glutamic acid) ( -PGA). Further adding of positively charged poly(L-lysine) (PLL) lead to ionic gelation and formed a nanogel with the MnFe 2 O 4 NPs encapsulated inside. PEGylation was also performed to enhance the biocompatibility of the nanogel. Since the outer surface of the nanogel is positively charged, QD800 (COOH), a negatively charged QD, was attached to the nanogel, forming a magnetofluorescent polyelectrolyte nanocomposites (MagFL-PEN). The T 2 relaxivity of the MagFL-PEN was measured to be 436. 8 to form IONP@PPy nanocomposites, and then further modified the nanocomposites with PEG to obtain IONP@PPy-PEG nanoparticles. To prove the bimodality of the synthesized nanoparticles, tumor-bearing mice were injected with IONP@PPy-PEG nanoparticles and then imaged in MR and photoacoustic system (Fig. 7) . The excellent NIR absorbance of PPy was also utilized for photothermal therapy. 77 
LANTHANIDE UPCONVERSION PARTICLES
All the previously mentioned optical imaging is based on downconversion phenomenon, that is, the emitted photons have lower energy than the absorbed photons. Upconvertion luminescence (UCL) is a phenomenon that light with shorter wavelength is emitted after sequential absorption of longer wavelength light. Lanthanide doped nanoparticles (Ln-NPs) is so far the most widely studied upconversion molecular probe. Ln-NPs are commonly made by doping trivalent lanthanide ions to a host lattice. 78 79 Due to the high X-ray attenuation of lanthanide elements, LnNPs can be readily used as Optical/CT bimodal contrast agent. [80] [81] [82] In addition, Gadolinium ions are often co-doped with upconverting lanthanide ions to introduce the MR property, and since doped Gd 3+ ions are confined in a more rigid crystal matrix, it is considered much less toxic compared to the clinically available Gd 3+ -chelate complexes. 40 Moreover, the Gd 3+ ions may enhance the PL by acting as an intermediator which harvest the excitation energy and then transfer it to the nearby luminescent Ln ions. 83 84 SPION can be incorporated with Ln-NPs in a core/shell configuration. 81 85 Ln-NPs have also been reported being labeled with radioactive isotopes and then used as contrast agent for PET. 86 87 or SPECT.
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AREF 4 (A-alkali metal, RE-rare earth elements) fluorides such as NaYF 4 is considered one of the mostly efficient host materials for upconverting lanthanide due to its lattice consistency with Ln ions, chemical stability and low phonon vibration. 79 In order to produce MRI/Optical bimodal probe, NaGdY 4 is often used instead of NaYF 4 , in which the Yttrium ions are substituted by Gadolinium ions. [88] [89] [90] [91] One example of such kind of codoped nanoprobes was reported by Zhou et al. 86 The NaY 0 2 Gd 0 6 Yb 0 18 Er 0 02 F 4 nanoparticles were synthesized in organic solvent with hydrophobic oleic acid capping. Further ligand exchange replaced the oleic acid coating with hydrophilic citrate coating. The shape of the citrate capped NPs (cit-NPs) are slightly elliptical with average core size of 19-22 nm (determined by TEM) and hydrodynamic size of 28.2 nm (determined by DLS). The citNPs were additionally functionalized by incubation with 18 F containing solution and became a PET/MR/UCL triple functional probe. However, the as-prepared cit-NPs have a green light emission when excited by a CW 980 nm laser. The short penetration of green light has limited the in vivo optical imaging capability of the tri-modality probe. The author conducted in vivo MR and PET imaging on mice but the optical imaging was performed in vitro with KB cells tissue section. Another work reported by the same group 88 4 NPs with polyethyleneimine (PEI) or 6-aminocaproic acid (6AA) capping through a one-pot hydrothermal reaction. 51 The sizes of the doped MFNPs are relatively small (14 ± 2 nm for PEI capped NPs and 13 ± 2 for 6AA capped NPs, estimated by TEM). The crystal structure of this KGdF 4 MFNPs remained cubic at this small size, this is considered as an advantage over the Ln doped KYF 4 NPs, in which the crystal phase transforms from hexagonal to cubic and dimes the upconversion luminescence. 95 In vitro upconversion imaging was performed on HeLa cells incubated with the synthesized KGdF 4 MFNPs. The cellular uptake efficiency of PEI capped NPs was found much higher than that of 6AA capped NPs. Although no MR imagining was performed, the high magnetic mass susceptibility (8 62 × 10 −5 emu g −1 Oe −1 of the PEI-MFNPs indicates the potential of this particle as optical/MRI bimodal contrast agent.
To further enhance the photo-stability, Chen et al. synthesized Ln-NPs with a core/shell configuration. 91 The Tm 3+ doped NaYbF 4 core was synthesized first to provide the NIR-to-NIR upconversion photoluminescence. Then a shell of NaGdF 4 was grown on the NaYbF 4 :Tm 3+ core to protect the PL and induce MR property. Compared to bare NaYbF 4 :Tm 3+ NPs, the luminescence intensities of core/shell NaYbF 4 :Tm 3+ /NaGdF 4 NPs are 3 times higher. This PL enhancement is caused by the suppression of quenching effect and the activation of upconverting ions in the core surface (the Yb 3+ and Tm 3+ ions in the core surface are provided a similar lattice environment with those inside the core matrix). In addition, the PL decay of the core/shell NPs was much slower than that of the bare NPs. The T 1 relaxivity was measured to be 2.6 mM −1 s −1 . The same group also reported another similar core/shell NP with a NaGdF 4 :Er 3+ , Yb 3+ core and a NaGdF 4 shell. 89 The bimodal capability of this core/shell NPs was demonstrated by wide-field cell imaging on breast cancer cells incubated with the core/shell NPs and MR imaging on the respected cell pellet. Their works provided a good example of combined doping and core/shell strategy. A more detailed protocol on how to synthesize core/shell, Ln-doped NaGdF 4 NPs has been reported by Wang et al. recently. 96 The core NaGdF 4 was first synthesized by co-precipitation of lanthanide fluoride and long-chain hydrocarbon, unsaturated fatty acids was also added as the capping agent to control the particle growth. Then the pre-synthesized core NPs was used as template according to which the outer shell grew epitaxially. Lanthanides doping was achieved concomitantly with particle growth, and different Ln ions can be doped into different compartments to achieve multi-color emission.
Cheng et al. integrated Ln-NP with ultrasmall SPION through a layer-by-layer self-assembly process. 85 PAA coated hexagonal Ln-NPs (NaYF 4 :Yb 3+ /Er 3+ were mixed with dopamine modified ultrasmall SPIONs (5 nm). The SPIONs were attached to the Ln-NPs by electrostatic attraction. Then negatively charged Au seeds were added and formed an Au shell on the surface of the SPION-LnNP complexes. The synthesized nanoparticles were further functionalized with PEGylation through gold-thiol bonding. Hydrodynamic diameter of the PEGylated MFNPs was measured to be 230 nm. Folic acids were also conjugated to the MFNPs in order to target cancer cell specifically. The MFNPs have a high transverse (T 2 relaxivity of 352.8 mM −1 s −1 (7T). Successful UCL and MR imaging were performed in vitro and in vivo (Fig. 8 ). What's more, the gold shell, which has excellent surface plasmon absorption, can be utilized for photo thermal therapy (PTT). Cancer cells incubated with the MFNPs were effectively destructed after exposure to NIR laser. However, the gold shell also causes quenching to the upconversion luminescence. Luckily, due to the intermediate SPION layer, the quenching effect is much weaker compared to Ln-NPs with directly-attached gold shell. 97 the emission, resulted in an enhanced emission compared to the uncapped ones. The MR properties were measured at 4.7T. 104 What is particularly interesting about Paik's work is that through the addition LiOH as shape directing agent, the shape of the Gd 2 O 3 NPs can be tuned from tripodal to triangular shape. The morphology of NPs has been reported to have influence on cellular uptake, 106 107 biodistribution. 108 and cytotoxicity. 109 As most multimodal probes are in spherical shape, Paik's work represents an alternative perspective to design target-specific, biocompatible nanoprobes by shape controlling. Apart from doping, Gd 2 O 3 NPs can also be conjugated with other imaging probes. Recently, Li et al. conjugated PEGlyted Gd 2 O 3 NPs with aptamer functionalized silver nanoclusters (aptamer-Ag NCs). 110 The conjugation was achieved by covalent bonding between the carboxylic groups on the surface of PEG-Gd 2 O 3 NPs and the amino groups from the aptamer. The fluorescence of aptamer-Ag NCs and the relaxivity of Gd 2 O 3 NPs were well retained after the conjugation. Subsequently, MR/Optical imaging was conducted on MCF-7 cells to demonstrate the dual-modal imaging capability of PEG-Gd 2 O 3 /aptamer-Ag nanoprobe. Enhanced cells uptake of the nanoprobe was also observed due to the presence of aptamers as targeting ligands.
Currently, the clinical MRI community is paying more and more attention on high magnetic field strength (>3T) MRI as it can provide image with higher signal-to-noise ratio. 111 112 At this strong magnetic field, Gd 3+ based contrast agents exhibit lower relaxivity and magnetization. 111 113 Effort has been invested to explore the potential of other paramagnetic lanthanide ions, including Dy 3+ , Pr 3+ , Sm 3+ , Ho 3+ , Er 3+ , and Yb 3+ , as MRI contrast agents. 114 115 Compare to Gd 3+ ions, those paramagnetic ions have shorter electronic relaxation time and mainly affect T 2 contrast. Among those lanthanides, Dy 3+ is attracting most of the research interest due to its short relaxation and high magnetic moment. 114 And just like other lanthanide ions, the optical property of Dy 3+ can be manipulated through doping in order to be applied for optical imaging. One good example was reported by Das and his colleague.
111 Dy 2 O 3 nanocrystals with an average diameter of 3 nm were synthesized through a stepwise thermolysis of Tb-Dy-oleate complex at 280 C. Tb 3+ ions were doped to enhance the luminescence. The transverse relaxivity (T 2 was measured to be 2.17 mM −1 s −1 at 7T magnetic field. The contrast enhancement is demonstrated by phantom imaging (Fig. 9(a) In vivo MR imaging was conducted on a tumor-bearing nude mouse (Fig. 9(b) ). The contrast enhancement can be clearly observed by comparing the injection site and un-injected site (Fig. 9(c) ). The optical imaging potential of Dy 2 O 3 nanocrystal was demonstrated by confocal imaging of human lung epithelial cells (BEAS-2B) that has been incubated the nanocrystal. A bright green fluorescence was observed. However, the imaging was based on down-conversion with an excitation of 275 nm. The same group also reported another Dy 3+ based nanocrystal: NaDyF 4 :Yb 3+ /NaGdF 4 :Yb 3+ , Er 3+ . The upconverting poisoning effect of Dy 3+ ions was utilized to generated NIR-to-VIS upconversion fluorescence. A photosensitizer (chlorin e6) was also conjugated to the NPs to make it a theranostic nanoprobe. 116 
CARBON-BASED NANOPROBES
Carbon Nanotubes Ever since its discovery in 1991, 117 Carbon Nanotubes (CNTs) have become one of the hottest materials in the research community due to its unique physical, chemical and biological properties. In the bio-imaging field, CNT, particularly single walled CNTs (SWNTs), based nanoprobes have also been extensively investigated. 118 119 There are several characters that make CNTs a good bio-imaging probe: With proper functionalization such as PEGylation, CNTs have been proved to have very low toxicity by various in vitro and in vivo studies. 120 SWNTs exhibit strong fluorescence emission in the NIR region. 121 The high NIR absorbance of CNTs makes it a good contrast agent for photoacoustic imaging. 27 SWCTs have also been utilized in Raman imaging due to its unique Raman signature and large scattering cross-section. 122 The good echogenicity of multi walled CNTs (MWNTs) can be utilized for contrast enhancement in ultrasound imaging. 123 Metal catalysts are often used in the fabrication CNTs and the residual metal ions enable CNTs to function as MRI contrast agents. 124 Besides exploiting the intrinsic properties of CNTs, additional imaging modalities can be integrated with CNTs through conjugation. The large surface area of CNTs can be functionalized and then linked with other imaging probes, including radio-isotopes, 125 iron oxide, 126 127 Gd 3+ chelates, 128 lanthanide nanocrystals 129 and QDs. 130 By sealing the endings of CNT, a large internal cavity can be created, in which a great amount of imaging and therapeutic agents can be loaded. 131 132 Recently, Chao et al. demonstrated human mesenchymal stem cells (hMSCs) labeling with protamineconjugated SWNTs and successfully conducted in vivo Raman/PAT/MRI triple modality imaging. 124 The SWNTs were synthesized by high-pressure CO disproportionation method, facilitated by metal catalyst. To make the SWNTs water dispersible, they were further PEGylated through sonication with C18PMH-PEG-NH 2 , a PEGgrafted amphiphilic polymer. Protamine was also conjugate to the PEG-SWNTs to enhance the cellular uptake. A considerable amount of ferric nanoparticles was found remain in the functionalized SWNTs, which brings a high T 2 relaxivity of 482.6 m M −1 s −1 . In vivo stem cell mapping was performed on a nude mouse model. hMSCs with and without SWNTs labeling were injected to a mouse subcutaneously. And then the mouse was imaged by Raman spectroscopic mapping, MR imaging and photoacoustic imaging. In all three imaging modalities, the site with SWNT-labeled stem cells injection shows notable differences compared to the control site (Fig. 10) .
Instead of working as contrast agents, Chen et al. utilized CNTs as a nano-platform to which other imaging probes are attached. 132 The internal cavity of CNTs was filled with Fe 3 O 4 nanoparticles while the exterior surface was modified with dispersing agent poly(sodium 4-styrenesulfonate) (PSS). CdTe QDs was encapsulated with a thin SiO 2 layer (HQDs) and then capped with poly(allylamine) (PAH). By conjugating the HQDs and CNTs, a magnetofluorescent nano-complex was created. Transferrin was attached to the CNTs to enhance the tumor targeting capability. Doxorubicin hydrochloride (DOX) was also loaded to the CNTs, which make the nano-complex a theranostic ensemble (Fig. 11) Graphene/Graphene Oxide Graphene is a carbon monolayer in which the atoms are arranged in hexagonal (honeycomb) lattice, 133 it can be described as an unzipped SWNT. Graphene shares many similar features with CNTs, including large surface area for drug/probe loading and high NIR absorbance. 134 Therefore graphene and its derivative (e.g., graphene oxide (GO) and reduced graphene oxide (RGO)) have also been studied extensively in the bio-imaging community. Due the presence of large amount of reactive oxygen groups, GO and RGO are more commonly used for biological applications as a versatile nanoplatform. Those reactive groups can be utilized to crosslink with hydrophilic capping molecules to prevent aggregation and to reduce cytotoxicity. 135 Then additional therapeutic/diagnostic agents can be then conjugated with the functionalized GO/RGO. In the work reported by Shi et al., A MRI/CT dualmodality probe was synthesized by crosslinking graphene oxide with IONPs and gold nanoparticles (AuNPs). 136 Here, graphene oxide was used as a nanoplatform to integrate IONPs and AuNPs. The IONPs and GO was first integrated by a one-step hydrothermal reaction and then AUNPs are attached to the GO through seeded crystallization. The as prepared AuNPs-IONPs-GO nanocomposite was further functionalized with lipoic acid modified PEG (LA-PEG) and folic acid conjugated LA-PEG (LA-PEG-FA). In vivo MRI/CT dual-model imaging was conducted with tumor-bearing BALB/c mice. Clear contrast enhancement can be observed in both MR and CT images. In addition, the high NIR absorbance of nanocomposite was utilized to perform photothermal therapy (PTT). The mice were irradiated under an 808-nm laser at the power density of 0.75 W/cm 2 for 5 min. The photothermal effect was evidenced by the IR thermal images of the mice and the temperature change of tumor. The efficacy of the PTT treatment was evaluated by post-treatment tumor growth. In another similar work reported by the same group, IONPs were also anchored to RGQ, in order to offer additional functions. 137 The difference is that the high NIR absorbance of graphene is used not only for PTT but also for photoacoustic imaging. The RGO-IONPs were functionalized with PEG and then labeled with 125 I and Cy5. Blood circulation, bi o-distribution studies and multimodal imaging were then conducted on 4T 1 tumor-bearing mice (Fig. 12) .
Another interesting derivative from graphene is graphene quantum dots (GQDs). GQDs are small luminescent fragment (<20 nm in size) of graphene, produced by either fragmentation of graphene sheet or chemical synthesis. 138 It is often confused with carbon dots (CDs, which will be discussed later) due to the similar properties. So far there is no strict boundary to differentiate those two types of nanoparticles. One practical method is to differentiate GQDs with CDs by their morphologies. Produced from graphene sheet, GQDs appears more "flat" while CDs are generally spherical. The early studies of GQDs mainly focus on its physical properties. Recently, due to its excellent optical properties and low cytotoxicity, more and more researchers started to investigate the potential of GQDs as bio-imaging probe. Carbon Dots Carbon dots (CDs) are quantum sized (<10 nm) photoluminescent (PL) carbon particles. Due to its excellent biocompatibility, abundant nature and potential for largescale green synthesis, it has got significant attention in the bioimaging community as an alternative to heavy-metalcontaining QDs. 135 141 The synthetic methods of CDs are generally categorized into two types: top-down approach, including arc discharge, laser ablation, and electrochemical oxidation, where CDs are "peeled off" from a bulk carbon source; bottom-up approach, including thermal/acidic oxidation, hydrothermal reaction, and microwave/ultrasonic methods. A clear understanding of the luminescent origin is still missing. However, it is believed that the PL property is strongly related to the surface passivation/oxidation. Sun et al. argued that surface energy traps cause the luminescence. Those energy traps are stabilized by quantum confinement effect and become emissive after surface passivation. 142 This hypothesis is supported by the fact that many reported CDs require a passivation layer to exhibit PL. However, some CDs produced from bottomup methods can exhibit PL properties without any additional passivation agent. 143 144 This may be argued that those passivation-free CDs can only exhibit PL with the presence of solvent; the solvent molecules are providing the passivation effect to the suspending CDs. 145 Some researchers attribute the luminescence to the surface carboxylate group. 146 147 Since most of the as-synthesized CDs are made of particles with different size, the emission spectra of CDs are wide band spectra, characterized by an emission peak in short wavelength and a long "tail" 148 149 On the other hand, the wide emission spectra can be exploited for multi-color imaging. The emission spectra of CDs are also excitation dependent, and the peak position has a red-shifter when exited with longer-wavelength light. One drawback for CDs as in vivo imaging probe is that the emission peaks of currently reported CDs are limited in the UVVis region, which will be strongly scattered by biology tissue. Some CDs exhibit detectable emission at VIS-IR region, and might be suitable for in vivo imaging. Tao et al. synthesized CDs by treating CNTs and graphite with mixed acid. 150 The CDs were used for in vivo imaging of mice under different excitation. As show in Figure 13 , the CDs' fluorescence can still be well distinguished with background autofluorescence at 704 nm excitation (770 nm emission).
Although CDs are being investigated as optical probe, not many CD based multimodality probes has been reported. Since doping has been used to enhance the quantum yield of CDs, magnetic moieties (Gadolinium, [151] [152] [153] iron oxide 154 may be doped into CDs to produce magnetoflorescent CDs. The surface functional groups also possess potential for covalent conjugation with other imaging or therapeutic agent. 155 One example of such kind of doped magnetoflorescent CDs was reported by Bourlinos et al. 151 The CDs are synthesized by thermal decomposition of tris(hydroxymethyl)aminomethane and betaine hydrochloride. Gadopentetic acid was added before the pyrolysis to incorporate the Gd 3+ ions (Fig. 14(a) ). The core size of the Gd-QCDs is ∼3 nm while the average hydrodynamic diameter is 4 nm. The Gd-QCDs have a wavelength-dependent emission in the UV-VIS region, with an emission peak in 445 nm. The author did not measure the relaxivity of the Gd-QCDs, but proved the MRI contrast enhancing capability of the Gd-QCDs by comparing the MR image of Gd-QCDs with a commercial T 1 contrast agent Gadovist (Fig. 14(b) ).
GOLD NANOPROBES
Nano-scaled (1-100 nm) gold particles (AuNPs) possess many distinct properties compared to bulk gold. Particularly, for bio-imaging application, the following features are considered most interesting: The absorbance and fluorescence of gold nanostructures is significantly enhanced with respect to bulk gold, and just like QDs, the absorption and emission wavelength can be tuned by manipulating the size and morphology of the nanoparticles. 156 Rod-shaped gold nanoparticles exhibit strong multi-photon fluorescence in NIR range and have been already applied to image cancer cells 157 and cerebral vasculature. 158 The heavy atomic weight of gold element makes it an ideal contrast agent for X-ray CT. Gold nanorod shows higher contrast enhancement compared to the commercial iodine CT contrast agent. 159 AuNPs are also holding the potential as MRI contrast agents due to their paramagnetic nature. 160 The strong electromagnetic enhancement of AuNPs can be utilized in surface-enhanced Raman scattering (SERS) essays. 161 At their plasmon wavelength, AuNPs show strong light scattering. This feature can be used for contrast enhancement in various optical imaging techniques. Au-NPs with various shapes, including nanoshells, 162 nanocages 163 and nanorods, 164 have been applied for OCT imaging. Besides, dark field microscopy imaging 165 and reflectance confocal microscopy (RCM) imaging 166 using Au-NPs have been reported. The excellent light absorption and efficient light-heat conversion of Au-NPs have been exploited for photothermal 167 (direct detection of generated heat) and photoacoustic 168 (detection of generated phonons) imaging. The absorption of AuNPs decreases as the 3rd power of diameter while scattering decreases as the 6th power of diameter. This means that below certain size, absorption will be the predominant event. Therefore, small Au-NPs are often used for photothermal imaging while larger AuNPs are more suitable for photoacoustic imaging. 161 The laser induced heat effect is also often used for photothermal therapy.
The first scientifically reported synthesis of colloidal gold particles can be traced back to the year of 1857, when Michael Faraday obtained a "ruby fluid" by stabilizing reduced gold chloride with carbon-disulfide. 169 Today, the similar principle is still followed in many nanoparticle preparation methods: gold salts are reduced with the addition of capping agents. The capping agents will prevent aggregation of particles and therefore the particles sizes are restricted in the nano range. With the development of nano-synthesis technology, controlled synthesis of AuNPs with various shapes and sizes are possible. 170 171 For bioimaging application, this means researcher can choose the optimal Au-NPs which suit the imaging targets.
Before applying AuNPs to bio-imaging applications, one essential step is to functionalize the particles surface. Many capping agents used in the synthesis of AuNPs are not biocompatible. For example, Cetrimonium bromide (CTAB), which is often used for morphology control during the Au-NPs synthesis, is found to be toxic. 172 A variety of functionalization methods, including ligand exchange, PEGlytion, silica/polymer coating and biomolecule capping, has been developed to in order to enhance the biocompatibility of AuNPs. 173 Additionally, the functionalized Au-NPs can be further conjugated with other imaging probe or therapeutic agents.
Without integrating with other imaging probes, the intrinsic properties has already enable AuNPs to function as nanoprobes in multimodal imaging. Recently, Hembury et al. synthesized gold-silica quantum rattles (QRs) and applied them in NIR fluorescence, photoacoustic, and MR imaging. 174 The Au-SiO 2 QRs were synthesized by restricted gold nucleation within the mesoporous silica nanoparticles. The as synthesized QRs exhibit well-defined hollow spherical shape (∼150 nm diameter) with mesoporous silica shells (∼25 nm). Two types of gold nanoparticles were produced and separately distributed: small Au-NPs (<2 nm) inside the silica shell and large AuNPs (∼7.3 nm) in the macrocavity (Fig. 15) . The tri-modal imaging potential of the Au-SiO 2 QRs was investigated by NIR/photoacoustic/MR imaging in an LS174T-luc tumor bearing mouse model. In addition, the Au-SiO 2 QRs were also tested in photothermal therapy with HeLa cells and tumor bearing mouse. Efficient and localized tumor ablation was observed after NIR irradiation (671 nm, 38 W · cm −2 , 10 min). Drug loading efficiency was tested by conjugating DOX with the QRs.
It is also very common to integrate AuNPs with other imaging probes, such as QDs, 175 176 IONPs, 177 Gd 3+ chelates 178 and radionuclide, 179 to produce multimodal probes. Besides, gold has been widely used as shell materials to produce multimodal nanoprobes with Core/Shell configuration. 180 181 Recently, Coughlin et al. conjugated gadolinium chelates with gold nanoshells and successfully applies this nanocomplex in multimodal imaging. 178 The ∼16 nm gold shells were grown on the surface of ∼120 nm silica nanoparticles. The Au-nanoshells were further functionalized with PEG and then conjugated with Gd-DOTA chelates. The synthesized gadoliniumnanoshell (Gd-NS) complexes exhibit a high T 1 relaxivity of 37 mM −1 S −1 . In vivo T 1 -MR and CT imaging were conducted on a tumor-bearing mouse after intratumoral injection of Gd-NS. Compared to images of control groups, the Gd-NS produced significant contrast enhancement (Fig. 16 ). wide range. 182 Generally, MOFs can be characterized by their ultra-high porosity and exceptionally large surface area, which makes them a promising material in gas storage, separation and catalysis. 183 Recently, nanoscale MOFs (NMOFs) have been attracting more and more attention in the bio-imaging field. First, the diversity of NMOFs makes it very convenient to tailor NMOFs for different bio-imaging application. Second, by crosslinking organic and inorganic moieties, the strengths of the types of materials can be combined. And last but not the least, MOFs is generally biodegradable due to the relatively weak metalligands bonds, which reduced the risk of long-term biological retention and accompanying side effect. 184 MOFs based nanoprobes can be prepared by two different strategies: to incorporate the imaging moieties during the synthesis of MOFs or to load imaging probes by post-synthesis treatment. The direct incorporation methods normally involve metal ions or ligands that can function as imaging probes. MOFs contain magnetic ions have been reported as MRI contrast agent. 185 186 Lanthanidebased MOFs possess the potential as optical imaging probes. 187 MOFs with iodinated ligands can be used for contrast enhancement in X-ray CT. 188 For the postsynthesis strategy, imaging probes can be loaded to the pores of MOFs through covalent conjugation or noncovalent encapsulation.
METAL-ORGANIC FRAMEWORKS
To synthesize multimodal MOF probes, different imaging probes can be integrated in the same MOFs. In a very recent work reported by Tian et al., a MRI/CT bimodal MOF probe was synthesized by applying both of the aforementioned loading strategies. 186 Gadolinium MOFs (GdMOFs) were first synthesized through a surfactant (CTAB) facilitated method with Gd 3+ as the coordinating ions. Then Poly(acrylic acid) (PAA) was used to functionalize the GdMOFs. Next, gold ions were bonded to the carboxylic acid groups of PAA. Finally, by reducing the Au ions, gold nanoparticles (average size 4 ± 2 nm) were produced at the surface of PAA-GdMOFs (Fig. 17) . The bimodal imaging performance of the nanoprobes was only evaluated by CT/MR imaging of Au-PAA-GdMOFs solution with various concentrations. Further in vitro and in vivo imaging applications are expected.
PORPHYRINS-BASED NANOPROBES
Porphyrins are a groups of aromatic molecules that are widely occurring in nature. Porphyrin structures play important roles in many vital metabolization processes including photosynthesis reaction (porphyrin presented in chlorophyll) and oxygen transportation (porphyrin presented in hemoglobin). Intrinsic porphyrin-containing hemoglobin has already been used as contrast agent for phocoustic imaging 189 and functional MRI. 190 On the other hand, exogenous porphyrins are also holding a potential as molecular imaging probes due to its NIR fluorescence. 191 The metal chelating capability can be utilized to load magnetic ions 192 or radionuclides. 193 In addition, due to the high singlet oxygen yield, porphyrins and their derivatives have become one of the most popular photosensitizer in photo dynamic therapy (PDT). 194 After delivery to the tumors site, porphyrins generate cytotoxic singlet oxygen to kill the tumor cells. One problem of porphyrin derivatives is that they are often hydrophobic. Therefore, porphyrins are often incorporated with phospholipid to form porphyrin liposome (porphysome) or porphyrin-lipid nanocomplex. 195 While mostly applied in optical/photonic imaging and therapy, porphyrin based nanoparticles can also be integrated with other imaging probes. Taking advantages of the porphyrin's intrinsic metal chelating properties, Liu et al. incorporated 64 Cu to porphysome with an exceptionally high loading capacity (2800 Ci/ mol per particle). 196 The 64 Cu chelation was found stable in vivo for at least 30 hours, which is essential for the co-registration of optical/PET image. The 64 Cu-phorphysome was applied for PET/optical dual-modal imaging on prthotopic prostate tumor bearing mouse models. 197 Similar to liposomes, porphysomes can also be used to conjugate or encapsulate other imaging probes. Rieffel et al. encapsulated UCNPs (core-shell NaYbF 4 :Tm 3+ -NaYF 4 with 64 Cu labeled porphyrin-phospholipid (PoP). 198 After functionalization with PEG-lipid, the 64 Cu-PoP-UCNPs were applied for hexamodal imaging: down-conversion fluorescence (FL), up-conversion luminescence (UC), PET, CT (the dense electron content of UCNPs provides high X-ray attenuation), Cerenkov luminescence (CL) and photoacoustic imaging. (Fig. 18) 
DENDRIMER-BASED NANOPROBES
Dendrimers are defined as highly branched synthetic macromolecules with tree-like configuration. Dendrimers are considered as excellent nanoplatform due to their branched interior, globular shape and abundant surface functional groups that enables further modifications. 199 Multimodal dendrimer probes can be prepared by conjugating intrinsically multimodal contrast agents with dendrimer or by conjugating different contrast agents with same dendrimer. The Raymond group developed a series of bifunctional lanthanide (Ln) chelators, and those chelators can be further conjugated to functionalized dendrimers. In 2012, Andolina et with TREN-bis(1-Me)-3,2-HOPO-TAM-NX (X = 1, 2, 3) ligands and subsequently conjugated to the esteramide dendrimer (EA). The intrinsic fluorescent and magnetic nature of Ln ions makes the EA-Ln conjugates potential MRI/Optical bimodal probes. 200 Also using chelating method, Harrison et al. conjugated two contrast agents, Gd 3+ and fluorescein isothiocyanate, to a phenolic dendrimer core. The phenolic core was modified with amine-functionalized linkers in order to form stable bond with the fluorescein molecules (Fig. 19) . 201 Dendrimers have also been used to encapsulate other nanoparticles, such as Au-NPs 202 and IONPs, 203 to form dendrimer entrapped nanoparticles (DENPs). The dendrimer entrapment renders those nanoparticles with enhanced biocompatibilities and tunable surface functionalities. Recently, Chen et al. reported a stepwise method to prepared gold DENPs with Gd chelation. 204 First, amine-terminated generation 5 poly(amidoamine) dendrimers (G5-NH 2 Figure 18 . In vivo lymphatic imaging of 64 Cu-PoP-UCNPs injected mice. The particles were injected to the rear left footpad. Images were taken 1 hour after injection. The yellow arrows in (a) FL, (b) UC, (c) whole body PET, (d) merged PET/CT and (e) CL images indicate the accumulation of 64 Cu-PoP-UCNPs in the first draining lymph node. PA images before (f) and after (e) 64 Cu-PoP-UCNPs injection demonstrate the contrast enhancement. Previously un-detected lymph noted could be visualized after nanoparticle injection. Reprinted with permission from [198] conjugated with DOTA-NHS chelators. Next, the G5-DOTA nanocomplexes were functionalized by PEGlyted RGD peptides. Subsequently, Au-NPs were generated in the interior of RGD-G5-DOTA templated nanocrystallization. After chelation with Gd 3+ ions, the final step is to transfer the residual terminal amine groups to acetamide groups through acetylation (Fig. 20) . The as prepared Gd-Au DENPs-RGD probes have an average core size of 3.8 nm (determined by TEM). The hydrodynamic diameter is much larger (71.7 ± 0.8 nm, determined by DLS), but still within the appropriate range for biomedical application. After confirming the biocompatibility with MTT essay, the Gd-Au DENPs-RGD probes were applied for CT and T 1 weighted imaging on U87MG tumor bearing mice. Significant contrast enhancement can be observed by comparing the mouse injected with Gd-Au DENPs-RGD and the mouse injected with free RGD peptides.
NANOPROBES FOR PET IMAGING
Positron emission tomography (PET) has now been widely applied in both clinical and research. The basic principle of PET was proposed in the 1950s, when researchers start to realize that the high-energy photons produced by positron annihilation can be utilized to determine the 3-D position of certain substance. After mid-1980s, PET devices had become available for diagnostic imaging. Since then, significant advances in PET instrumentation, method and computational algorithm have been witnessed, which makes PET imaging a powerful imaging technique as we see it today. Generally, the PET protocol begins with injection of a radio labeled tracer. One of the most widely used radiotracers is 2-deoxy-2-( 18 F)fluoro-D-glucose (FDG), an analog to glucose in which the normal hydroxyl group is substituted by positron emitting 18 F isotope. After the injection, the radiotracer will accumulate in certain regions, to which the radiotracers have affinity. For example, the FDG will most probably accumulate in brain or tumor, which consumes a large quantity of glucose. The radionuclides will then decay and emit positrons. The ejected positrons will immediately combine with nearby electrons and undergo annihilation process. Two highenergy photons with same speed but opposite directions will be generated by this annihilation process. By detecting the generated photons, the position of the annihilation event can be determined. 206 While most of the clinical PET radiotracers are small molecules, there is an increasing interest to develop nanoparticle based PET probe in order to combine the quantitation of PET with specific targeting and multifunctionality of nanoparticles. The structure of nanoparticles and the wide variety of functionalization agent give nanoparticles a high freedom when choosing the radioligand. Chelating agent such as DOTA plays an important role to conjugate PET isotopes with nanoparticles.
Positron emission isotopes can be conjugated to QDs to produce Optical/PET bimodal probes. Compared to magnetofluorescent QDs, the smaller sensitivities discrepancy makes it practically easier to combine PET and Optical probes. 39 PET imaging has higher penetration depth and is more quantitative, while optical imaging can provide real time visualization. This kind of bimodal probe has been used to image cancer 207 208 and to study the biodistribution of QDs. 208 Another way to combine optical and pet imaging is to utilize the Cerenkov radiation (CR) phenomenon. CR occurs when charged particles travel in an insulating material with a speed higher than speed of light in that material. And this radiation can be detected by optical imaging system. 209 210 Positron-emitting nuclides, including fluorine-18, oxygen-15, gallium-68 and iodine-124, have enough energy to cause CR and hence can be used in CR imaging. 211 That is to say, NPs synthesized with only PET and MR imaging agents may be readily detectable by optical imaging system. Therefore, the development of CR imaging provided an easier strategy to prepare Optical/MRI/PET probes. However, the light produced by CR is mostly in the UV-VIS range, which may limit its in vivo application due to the high absorbance in biological tissues. Researchers have been trying to overcome this limitation by utilizing a process termed Cerenkov radiation energy transfer (CRET), in which a second fluorophore (such as QD) was conjugated with the PEI isotope. 212 The second fluorophore absorbs the short wavelength CR light and re-emit light in a much shorter wavelength, which is easier to detect.
Apart from PET/Optical integration, MRI/PET multimodal agent may be more promising in clinical application. Both MRI and PET have unlimited in vivo penetration depth and combined PET/MRI instrument has been reported. 213 One proposed strategy to apply PET/MRI imaging is to use PET whole body screen to identify the region of interest and then use MRI to obtain the high-resolution image of that specific region. This strategy is expected save a lot of time that is otherwise required for whole body MRI screen. 6 Tu et al. reported a MRI/PET probe made by conjugating 64 Cu-DOTA complex with dextran coated iron oxide (DIO) nanoparticles. 214 This bimodal probe was specially modified with maleic anhydride to obtain a high negative surface charge. The increased anionic charge helps the probe to target as the scavenger receptor type A (SR-A) which is commonly expressed in macrophage events. The core size of the maleylated DIO (MDIO) was determined around 7-8 nm, similar to that of non-maleylated DIO, but the maleylation significantly increased the hydrodynamic size (DIO-38.1 nm, MDIO-62.7 nm). The T 2 relaxivity of MDIO is measured to be 95.8 mM −1 s −1 (1.7T). In order to attest the specific binding ability of MDIO, the author further labeled the MDIO with fluorescent dye 5(6)-TAMRA-SE. The fluorescent image on P388D1 cells (mouse macrophage cell line) and T 2 MR image on cell lysate proved the enhanced cell uptake of MDIO. This also suggests that the MDIO can be functionalized to become a triple functional probe. Xie et al. reported a similar PET/Optical/MRI triple nanoprobe by labeling human serum albumin (HAS) encapsulated IONPs with 64 Cu-DOTA and NIR dye Cy5.5. 38 The HSA matrices prolonged the NPs' circulation time. lesion. Different from the dual-labelling strategy, Park et al. reported a more facile preparation of triple functional IONPs with single labelling. 37 Thermally crosslinked IONPs were labeled with positron emitting 124 I. 124 I decays with a strong + mean energy, leading to strong Cerenkov radiation, which can be used for Cerenkov luminescence imaging. The strong tissue absorption of CR light is partially offset by the high emission intensity.
Optical/microPET/MRI triple modality imaging was conducted on 4 T 1 tumor bearing mouse (Fig. 21) . 53 215-217 so here we will just make a brief summary. Targeting ligands are often used in targeted drug delivery. To differentiate pathological cells with healthy cells, those targeting ligands are designed to bind with receptors that are over expressed in pathological cells but much less expressed in normal cells. Through receptormediated endocytosis, these additional targeting ligands can enhance the specific cell binding and internalization. Without targeting ligand, NP internalization is mainly determined by non-specific interaction with cell membrane, which can be relatively slower, especially when the NPs are shielded with PEG layer. 53 For nanoprobes, targeting ligands can also facilitate the particle localization in lesion. 218 In terms of particle morphology, targeting ligands are normally presented at the outer surface, on top of the capping layer, to achieve maximum receptor binding. According to their molecular constitution, targeting ligands can be classified into five groups: Full antibody, antibody fragment, peptide, aptamer and small molecules. Each group has its own advantages and limitations on targeting efficacy, stability and ease of preparation. 217 Significant effort has been put on monoclonal antibodies as targeting ligands, and several successful therapies have been reported based on engineered antibodies. 219 Despite those successes, the large molecule size, complex modification process and high batch-to-batch variation of monoclonal antibodies have driven researcher to search for alternative ligands. Full sized antibodies can be decomposed into different fragments using proteolytic digestion. Some of those fragments retain the receptorbinding capability. Compare to the full antibody, antibody fragment are smaller and easier to manipulate. 220 Peptide is another attractive candidate for targeting ligands. Thanks to the development of different peptides library and screen technology, a variety of peptides have been discovered to have high affinities with certain receptors. 221 Other than proteomic ligands, small nucleic acid ligands, referred as aptamers, have also been attracting many interests. Aptamers can bind with a wide range of receptors with an affinity comparable to antibodies. More excitingly, aptamers can be synthesized with large scale and high batch-to-batch consistence, using an in vitro chemical technique known as systematic evolution of ligands by exponential enrichment (SELEX). 222 223 Some small molecules have also been found to have targeting capability. One of the promising tumor targeting ligands is folic acids, which target to over-expressed folate receptor in cancer cells. 224 The quantity of targeting ligands affects the targeting efficacy. Generally, more targeting ligands lead to better targeting effect. Nanoparticles which are conjugated with multiple ligands (multivalency) normally possess enhanced affinity, slower disassociation and better biodistribution, compared to stand-alone targeting ligands (monovalency). 225 However, for PEGlytated nanoparticles, too many surface ligands may be detrimental to the stealth capability. Studies have shown that high density of surface ligands leads to shorter circulation and lower tumor localization compared to nanoparticles conjugated with less ligand. 226 227 On the other hand, the morphology of the PEG chains also affects the targeting and stealth capability. At moderate concentration, the lateral pressure between PEG chains forces them to extend into a brush conformation. If the PEG density is too high, the PEG chain will tangle itself, forming a random-coil conformation, also known as the mushroom conformation. 228 Brush PEG layer provides better stealth effect than mushroom PEG chains due to its greater protein repulsion. 229 Targeting ligands that are grafted on the extended PEG chains have more chance to interact with receptors. To achieve optimal combination of specific targeting and stealth effect, the concentrations of targeting and stealth agents should be carefully balanced.
TARGETING LIGANDS

CONCLUSION
The development of MFNPs as molecular imaging contrast agent is expected to help reveal the molecular pathways of disease development, enable early detection and intervention for many diseases that are hard to deal with using the conventional generalized approaches. A variety of interrogation, integration and surface modification methods have been proposed by researchers in the recent past to combine different imaging modalities and enhancing targeting capabilities. In this review, we introduced several representative works of MFNPs preparation (Listed in Table II ). However, the applications of MFNPs are still limited in research community. MFNPs have been extensively exploited in small animal imaging and in vitro imaging. But many challenges remain to be overcome before MFNPs can be applied in clinical arena as a diagnostic tool. The accuracy and reproducibility of different MFNPs need to be systematically determined, the synthetic methods need to be standardized and the biological fate needs to be followed to ensure their biocompatibility. Theoretical modeling of material integration is also needed to guide the search for optimum MFNPs. All those challenges cannot be resolved without an inter-disciplinary collaboration between chemist, biologist and clinician. It is envisaged that the new research thrust area combining these MFNPs including carbon dots can lead to new generation multimodal molecular probes for introducing a paradigm shift in clinical diagnostics. 
